Cold Urticaria

2

Review clinical trials related to Cold Urticaria. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.

Participants needed: 240
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Celldex TherapeuticsUpdated: Jul 1, 2026Locations: 73
Eligibility criteria

Males and females, >/= 18 years of age. [+10]

Women who are pregnant or nursing. [+7]

Status: Recruiting

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

This is a first-in-human study aimed at determining the safety of a single dose of GTX-B001 in healthy participants and in people with chronic inducible urticaria.

Participants needed: 72
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Granular Therapeutics LimitedUpdated: Jan 30, 2026Locations: 2
Eligibility criteria

The subject is between 18 and 55 years of age (both inclusive) at the date of sc... [+7]

Presence of any clinically significant illness, such as cardiovascular, neurolog... [+7]